Intraperitoneal instillation of bupivacaine in gallbladder fossa and at trocar sites in reduction of postoperative pain after laparoscopic cholecystectomy: a prospective randomized controlled double blind trial

Paras K. Pandove; Nitish Arora; Arun Garg; Lovelesh Pandove; Ashwani Kumar

doi:10.18203/2349-2902.isj20171021

Authors

Paras K. Pandove Department of General Surgery, Government Medical College and Rajindra Hospital, Patiala, Punjab, India
Nitish Arora Department of General Surgery, Government Medical College and Rajindra Hospital, Patiala, Punjab, India http://orcid.org/0000-0002-4315-9666
Arun Garg Department of General Surgery, Government Medical College and Rajindra Hospital, Patiala, Punjab, India
Lovelesh Pandove Gian Sagar Medical College and Hospital, Patiala, Punjab, India
Ashwani Kumar Department of General Surgery, Government Medical College and Rajindra Hospital, Patiala, Punjab, India

DOI:

https://doi.org/10.18203/2349-2902.isj20171021

Keywords:

Bupivacaine, Peritoneal analgesia, Trocar site analgesia, Trocar site pain

Abstract

Background: Pain relief remains landmark achievement attributed to laparoscopic cholecystectomy. Post laparoscopic cholecystectomy patient still complains of incisional pain, shoulder pain and vague upper abdominal pain. A simple method of portal or incisional infiltration and intraperitoneal spraying of a local anaesthetic agent over gall bladder fossa can reduce postoperative pain. The mean duration of action of bupivacaine hydrochloride is 8.07 hours which is 2-3 times longer than lignocaine.

Methods: This study was conducted to determine whether local infiltration of bupivacaine at trocar sites and gall bladder fossa has any effect in postoperative pain relief. This prospective study was conducted on 60 patients (3 groups) undergoing laparoscopic cholecystectomy. In group A, 20ml of 0.25% bupivacaine was instilled subcutaneously at all trocar sites. In group B, 20ml of 0.25% bupivacaine was instilled in gallbladder fossa after removal of gall bladder. In group C, 20 ml bupivacaine was instilled at the gall bladder fossa and 20% was instilled at the trocar sites as mentioned for group A.

Results: Chi square analysis of NRS of pain at 1, 6, 12, 24 hours post operatively shows significant improvement in NRS scores in group A and C compared to group B.

Conclusions: Infiltration of 0.25% bupivacaine at all trocar sites with or without infiltration in gall bladder fossa is an effective method of postoperative pain relief when compared to infiltration of gall bladder fossa alone.

Metrics

Metrics Loading ...

Author Biography

Nitish Arora, Department of General Surgery, Government Medical College and Rajindra Hospital, Patiala, Punjab, India

Junior Resident

Department of General Surgery

Rajindra Hospital Patiala

References

Joris J, Cigarini I, Legrand M. Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth.1992;69:341-5.

Hasnain JV, Matjasko MJ. Practical anaesthesia for laparoscopic procedure. In: Zucker KA, ed. Surgical laparoscopy and endoscopy. St. Louis, Missourie: QMP Inc; 1991:77-85.

Pasqualcci A, Contardo R, Da Broi U. The effects of intraperitoneal local anaesthetic on analgesic requirements and endocrine response after laparoscopic cholecystectomy: A randomised, double blind controlled study. J Laproendosc Surg.1994;4(6):405-12.

Maharjan SK, Shrestha S. Intraperitoneal and periportal injection of bupivacaine for pain after laparoscopic cholecystectomy. Kathmandu Univ Med J (KUMJ). 2009;7:50-3.

Bisgaard T, Kehlet H, Rosenberg J. Pain and convalescence after laparoscopic cholecystectomy. Eur J Surg. 2001;167:84-96.

Parkhouse J, Lambrachts W, Simpson BRJ. The incidence of postoperative pain. Br J Anaesth. 1961;33(7):335-45.

Ragsale DS, Mcphee JC, Scheuer T, Catterall WA. Science. 1994;265:1724-8.

Yarov-Yarovoy V, Mcphee JC, Idsvoog D, Pate, Scheuer T, Catterall WA. Role of amino acid residues in transmembrane segments IS6 and II6 of the Na+ channel alpha subunit in voltage dependent gating and drug block. J Biol Chem. 2002;277(38): 35393-401.

Hollman A. Experience of LAC-43: a new anaesthesia with prolonged action in operative and therapeutic regional anaesthesia. Ann Chir Gynae Fen. 1966;55:322-6.

Watt MJ, Ross DM,Atkinson PS. A clinical trial of bupivacaine. Anaesthesia. 1968;23:2.

Tucker GT, Mather LE. Pharmacokinetics of local anaesthetic agents. Br J Anaesth. 1975;47:213.

Scott DB. Evaluation of the toxicity of local anaesthetic agents in man. Br J Anaesth. 1975;43:56.

Liu PL, Feldman HS, Covino BM. Acute cardiovascular toxicity of intravenous amide local anesthetics in anaesthetized ventilated dogs. Anesth analg. 1982;61:317-22.

Nath S, Haggmark S, Johnson G. Intracoronary injection of bupivacaine and lidocaine, an experimental study of cardiac rhythm, myocardial function and regional coordinator blood flow in Anaesthesized pigs. Upsala dissertations from faculty of medicine. 1985:226.

Widman B. LAC-43 (Marcain) a new local anesthetic. Acta anaesth Scandsuppl. 1966;25:59-66.

Sarac AM, Aktan AO, Baykan N. The effect and timing of local anesthesia in laparoscopic cholecystectomy. Surg Laparosc Endosc. 1996;6(5):362-6.

Lee IO, Kim SH, Kong MH. Pain after laparscopic cholecystectomy: The effect and timing of incisional and intraperitoneal bupivacaine. Can J Anaesth. 2001;48(6):545-50.

Scheinin B, Kellokumpu I, Lindgren L. effect of intraperitoneal bupivacaine on pain after laparoscopic cholecystectomy. Act Anaesthesiol Scand. 1995;39:195-8.

Weber A, Munoz J, Garleiz D. Use of subdiaphragmatic bupivacaine instillation to control post-operative pain after laparoscopic surgery. Surg Laparose Endose. 1997;7:6-8.